SEC Investigates Goldman Sachs Fraud

The Gold Standard No More? In a provocative IAM blog, Joff Wild asks will the Goldman Sachs brand be irreparably harmed from the SEC fraud investigation whether it secures a conviction or not? “Will Goldman Sachs pay a long-term reputation price for its current woes?” There is no way of measuring the precise impact, but the investigation [...]

Read more

Patent Troll Defense

Insurer Must Provide Defense Coverage To Hyundai in “Troll” Dispute In a story that received scant media coverage, an appeals court has decided that two insurance companies must provide defense coverage to Hyundai against patent infringement claims by a non-practicing entity (NPE), also known as a patent troll, because the company’s policy covers advertising injury. [...]

Read more

Surveying the IP Landscape

Help to Measure the State of IP, 2010 The importance of IP rights to business performance and value has grown significantly over the past decade. But where does the IP industry go from here? Last year IP Review, a crisp print and Web publication looked at the industry’s key trends. In the magazine’s State of the IP Industry, 2009 [...]

Read more

Gene Patents on Trial

An Invention or a Discovery? Human genes have been called unpatentable and anti-competitive. Everyone from the ACLU to patients who demand cheaper tests are weighing in on the debate. The controversy was complicated last week’s by the U.S. district court’s decision against Myriad Genetics, whose popular but costly diagnostic tests have until now been protected under patent law. Those who do not believe that products which [...]

Read more

The Intangible Investor

Great Expectations The cost to create, identify, secure, and generate a measurable return on innovation has skyrocketed. Yet the need to have identifiable IP rights is greater than ever. More people are affected by the deployment of new ideas. There is no dispute that innovation is an integral part of a global knowledge economy. What [...]

Read more